MSI-1436

CAS No. 186139-09-3

MSI-1436( Trodusquemine | Aminosterol-1436 | MSI1436 )

Catalog No. M12875 CAS No. 186139-09-3

An non-competitive, allosteric inhibitor of PTP1B with Ki of 0.6 uM for PTP1B1-405; antagonizes HER2 signaling.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 7380 Get Quote
50MG 23760 Get Quote
100MG 37620 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MSI-1436
  • Note
    Research use only, not for human use.
  • Brief Description
    An non-competitive, allosteric inhibitor of PTP1B with Ki of 0.6 uM for PTP1B1-405; antagonizes HER2 signaling.
  • Description
    An non-competitive, allosteric inhibitor of PTP1B with Ki of 0.6 uM for PTP1B1-405; antagonizes HER2 signaling, inhibits tumorigenesis in xenografts and abrogates metastasis in the NDL2 mouse model of breast cancer. Breast Cancer Phase 1 Clinical
  • In Vitro
    In HepG2, MSI-1436 (10 μM, 30 min) alone has no effect on phosphorylation of IRβ, but in conjunction with 100 nM insulin, MSI-1436 increases p-IRβ 18-fold over untreated cells and by approximately threefold over cells treated with insulin alone. MSI-1436's inhibition of TCPTP is approximately two logs less than the effect on PTP1B activity, with a resulting IC50 value of 224 μM. MSI-1436 (Trodusquemine, 10 μM) restores ERK phosphorylation in response to mGluR1/5 agonist DHPG in F11 neuronal cells. MSI-1436 (10 uM) rescues DHPG-induced holding currents and restores DSI in LMO4KO BLA neurons. MSI-1436 (0.1-100 μM) blocks PTP1B activity, has insulin-mimetic effects in cultured neuronal cells.
  • In Vivo
    MSI-1436 (10 mg/kg, i.p.) causes obesity-dependent body weight, reduces total body fat content and adipocyte size and lipid content of white adipose tissue of mice. MSI-1436 treatment significantly reduces plasma insulin levels. MSI-1436 (10 mg/kg, i.p.) increases phosphorylation of STAT-3 2.7-fold and, in conjunction with 100 U/kg insulin, p-IRβ increases threefold over insulin alone-treated rats. MSI-1436 (Trodusquemine) exhibits anxiolytic effect through a restoration of endocannabinoid (eCB) signaling within the amygdala. MSI-1436 (5 mg/kg, i.p.) has an anti-diabetic effect on diabetic mice, and is sufficient to suppress food intake and cause weight loss in CD1 mice.
  • Synonyms
    Trodusquemine | Aminosterol-1436 | MSI1436
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Protein Phosphatase/PTP
  • Recptor
    Protein Phosphatase/PTP
  • Research Area
    Cancer
  • Indication
    Breast Cancer

Chemical Information

  • CAS Number
    186139-09-3
  • Formula Weight
    685.0564
  • Molecular Formula
    C37H72N4O5S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC(C)C(CCC(C)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)NCCCNCCCCNCCCN)C)O)C)OS(=O)(=O)O
  • Chemical Name
    Cholestane-7,24-diol, 3-[[3-[[4-[(3-aminopropyl)amino]butyl]amino]propyl]amino]-, 24-(hydrogen sulfate), (3β,5α,7α,24R)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Krishnan N, et al. Nat Chem Biol. 2014 Jul;10(7):558-66. 2. Qin Z, et al. Biochem Biophys Res Commun. 2015 Feb 27;458(1):21-7.
molnova catalog
related products
  • Guanabenz

    Guanabenz (WY 8678) is an α2 adrenergic receptor agonist that is used as an antihypertensive agent.

  • AQX 1125

    AQX 1125 (Rosiptor) is a specific, orally bioavailable SHIP1 activator.

  • JTT-551 sodium

    JTT-551 sodium (JTT551, JTT 551) is a novel potent, selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) with Ki of 0.22 uM.